AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

University of Arkansas for Medical Sciences at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

University of Arkansas for Medical Sciences brings 3 presentations to AMP 2026 in Seattle. Its sessions centre on long-read sequencing, applied both to microbial identification and to brain tumour diagnostics, and it takes part in an early-morning haematopathology case study session. Topics include validated nanopore 16S and ITS sequencing for identifying bacterial and fungal isolates, and what comes after methylation classification for brain tumours.

OrganizationAMP 2026 Attendance
Med centres
Public academic health centre in Little Rock with medical and pharmacy schools and clinical molecular diagnostics laboratories.
Talk
Sat, Nov 14
2:30pm–3:00pm
Beyond Methylation Classification: The Next Generation of Brain Tumor Diagnostics Through Long-Read Sequencing and Precision Oncology
Brain tumour classification moving from methylation profiling toward long-read sequencing of genome, epigenome and transcriptome.
Technical Topics

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of Arkansas for Medical Sciences

Tell us what you sell and we’ll find the people at University of Arkansas for Medical Sciences most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction